Comparison of the safety and pharmacokinetics of ST-246® after i.v. infusion or oral administration in mice, rabbits and monkeys.
<h4>Background</h4>ST-246® is an antiviral, orally bioavailable small molecule in clinical development for treatment of orthopoxvirus infections. An intravenous (i.v.) formulation may be required for some hospitalized patients who are unable to take oral medication. An i.v. formulation h...
Guardado en:
Autores principales: | Yali Chen, Adams Amantana, Shanthakumar R Tyavanagimatt, Daniela Zima, X Steven Yan, Gopi Kasi, Morgan Weeks, Melialani A Stone, William C Weimers, Peter Samuel, Ying Tan, Kevin F Jones, Daniel R Lee, Shirley S Kickner, Bradley M Saville, Martin Lauzon, Alan McIntyre, Kady M Honeychurch, Robert Jordan, Dennis E Hruby, Janet M Leeds |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b5e19bc34bc24297a5169eda2e119b5a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Pharmacokinetics and interspecies allometric scaling of ST-246, an oral antiviral therapeutic for treatment of orthopoxvirus infection.
por: Adams Amantana, et al.
Publicado: (2013) -
Acta Nº246
por: Banco Central de Chile
Publicado: (2019) -
Resolución 246(XI): Educación para el desarrollo industrial = Resolution 246(XI): Education for industrial development = Résolution 246(XI): Education en vue du développement industriel
Publicado: (2014) -
Injection And Infusion Technology Disruption For Use In MRI
por: Kalmar M, et al.
Publicado: (2019) -
Propofol infusions using a human target controlled infusion (TCI) pump in chimpanzees (Pan troglodytes)
por: T. Miyabe-Nishiwaki, et al.
Publicado: (2021)